Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.36−0.03 (-8.70%)

Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –

Evogene cash

Cash and short-term investments held at the end of each period.

Evogene's cash was $9.32M at Jun 30, 2026. For fiscal 2025 it was $12.96M, down 15.3% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is $46.23M in fiscal 2020.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$12.96M	-15.3%
FY2024	Dec 31, 2024	$15.30M	-26.3%
FY2023	Dec 31, 2023	$20.77M	-28.3%
FY2022	Dec 31, 2022	$28.98M	-10.3%
FY2021	Dec 31, 2021	$32.33M	-30.1%
FY2020	Dec 31, 2020	$46.23M	+33.0%
FY2019	Dec 31, 2019	$34.75M	+498.1%
FY2018	Dec 31, 2018	$5.81M	+69.1%
FY2017	Dec 31, 2017	$3.44M	+6.1%
FY2016	Dec 31, 2016	$3.24M	-68.3%
FY2015	Dec 31, 2015	$10.22M	+96.1%
FY2014	Dec 31, 2014	$5.21M	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$9.32M	-1.8%
Q4 FY2025	Dec 31, 2025	$12.96M	-37.6%
Q2 FY2025	Jun 30, 2025	$8.33M	-58.8%
Q4 FY2024	Dec 31, 2024	$15.30M	-47.2%
Q2 FY2024	Jun 30, 2024	$9.48M	-67.1%
Q4 FY2023	Dec 31, 2023	$20.77M	-35.7%
Q2 FY2023	Jun 30, 2023	$20.23M	-52.7%
Q4 FY2022	Dec 31, 2022	$28.98M	-37.3%
Q2 FY2022	Jun 30, 2022	$28.87M	-7.1%
Q4 FY2021	Dec 31, 2021	$32.33M	-7.0%
Q2 FY2021	Jun 30, 2021	$42.76M	+203.3%
Q4 FY2020	Dec 31, 2020	$46.23M	+695.7%
Q2 FY2020	Jun 30, 2020	$31.07M	+804.6%
Q4 FY2019	Dec 31, 2019	$34.75M	+973.8%
Q2 FY2019	Jun 30, 2019	$14.10M	+37.9%
Q4 FY2018	Dec 31, 2018	$5.81M	+11.5%
Q4 FY2017	Dec 31, 2017	$3.44M	–
Q4 FY2016	Dec 31, 2016	$3.24M	–
Q4 FY2015	Dec 31, 2015	$10.22M	–
Q4 FY2014	Dec 31, 2014	$5.21M	–